Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Invested Capital (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Return on Invested Capital readings, the most recent being 0.01% for Q1 2026.

  • On a quarterly basis, Return on Invested Capital rose 1.0% to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 1.0% increase, with the full-year FY2025 number at 0.0%, up 85.0% from a year prior.
  • Return on Invested Capital hit 0.01% in Q1 2026 for Atara Biotherapeutics, up from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.13% in Q3 2023 to a low of 5.03% in Q1 2024.
  • Median Return on Invested Capital over the past 5 years was 0.0% (2025), compared with a mean of 0.36%.
  • Biggest five-year swings in Return on Invested Capital: crashed -500bps in 2024 and later surged 503bps in 2025.
  • Atara Biotherapeutics' Return on Invested Capital stood at 0.02% in 2022, then tumbled by -538bps to 0.11% in 2023, then soared by 108bps to 0.01% in 2024, then crashed by -156bps to 0.0% in 2025, then skyrocketed by 287bps to 0.01% in 2026.
  • The last three reported values for Return on Invested Capital were 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025) per Business Quant data.